sarcosine has been researched along with metallothionein in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danks, DM; McArdle, HJ; Mercer, JF; Sargeson, AM | 1 |
| Adam, V; Cernei, N; Eckschlager, T; Gumulec, J; Hubalek, J; Kizek, R; Kruseova, J; Masarik, M; Rodrigo, MA; Skalickova, S; Sochor, J; Sztalmachova, M; Trnkova, L; Zitka, O | 1 |
| Adam, V; Eckschlager, T; Guran, R; Heger, Z; Kizek, R; Kopel, P; Kulich, P; Masarik, M; Merlos Rodrigo, MA; Polanska, H; Stiborova, M | 1 |
3 other study(ies) available for sarcosine and metallothionein
| Article | Year |
|---|---|
Effects of cellular copper content on copper uptake and metallothionein and ceruloplasmin mRNA levels in mouse hepatocytes.
Topics: Animals; Cells, Cultured; Ceruloplasmin; Copper; Female; Gene Expression; Heterocyclic Compounds; Liver; Metallothionein; Mice; Polyamines; RNA, Messenger; Sarcosine | 1990 |
Effect of sarcosine on antioxidant parameters and metallothionein content in the PC-3 prostate cancer cell line.
Topics: Biomarkers, Tumor; Cell Line, Tumor; Cell Survival; Free Radical Scavengers; Humans; Male; Metallothionein; Prostatic Neoplasms; Sarcosine | 2013 |
Prostate tumor attenuation in the nu/nu murine model due to anti-sarcosine antibodies in folate-targeted liposomes.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Folic Acid; Humans; Liposomes; Male; Metallothionein; Mice; Models, Biological; Phosphatidylethanolamines; Prostatic Neoplasms; Sarcosine; Tumor Burden; Xenograft Model Antitumor Assays; Zinc | 2016 |